Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Publication year range
1.
Eur J Pharm Sci ; 143: 105120, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31669424

ABSTRACT

The repair process consists of molecular and cellular events that can be accelerated by specific therapies. Considering this, the objective of this study was to evaluate the effects of ibuprofen phonophoresis associated with gold nanoparticles in the animal model of traumatic muscle injury. Was used 80 male wistar rats divided into eight groups: Sham; Muscle injury (MI); MI + therapeutic pulsed ultrasound (TPU); MI + Ibuprofen (IBU); MI + GNPs; MI + TPU+ IBU; MI + TPU + GNPs and MI + TPU + IBU + GNPs. The lesion in the gastrocnemius was performed by a single direct trauma impact on the injured press. The animals were treated with pulsed ultrasound and the gel with gold nanoparticles and/or ibuprofen. The treatment was applied daily for 5 days and the first session was 12 h after the muscle injury. The gastrocnemius muscle was surgically removed for analyzes biochemical, molecular and histological. In the analyzes only the MI + TPU + IBU + GNPs group showed a reduction in TNF-a and IL-1 levels, with a concomitant increase in the levels of anti-inflammatory cytokines. In the analysis of oxidative stress, only the MI + TPU + IBU + GNPs group presented a reversal of the condition when compared to the MI group. In the histological analysis, the MI group presented a large cell infiltrate and a centralized nucleus and only the MI + TPU + IBU + GNPs group showed a structural improvement, also in the pain results the MI + TPU + IBU + GNPs showed a significant difference in comparison to the MI group (p<0.01). We believe that the effects of phonophoresis with anti-inflammatory drugs associated with gold nanoparticles may potentiate the reduction of the inflammatory response and regulate the cellular redox state.


Subject(s)
Analgesics/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Gold/administration & dosage , Ibuprofen/administration & dosage , Metal Nanoparticles/administration & dosage , Muscle, Skeletal/injuries , Muscular Diseases/drug therapy , Phonophoresis , Animals , Cytokines/immunology , Disease Models, Animal , Male , Muscle, Skeletal/immunology , Muscle, Skeletal/pathology , Muscular Diseases/immunology , Muscular Diseases/pathology , Oxidative Stress/drug effects , Rats, Wistar
2.
J Drug Target ; 28(3): 307-319, 2020 03.
Article in English | MEDLINE | ID: mdl-31379221

ABSTRACT

Studies have shown the benefits of gold nanoparticles (GNPs) in muscle and epithelial injury models. In physiotherapy, the use of the microcurrent apparatus is associated with certain drugs (Iontophoresis) to increase the topical penetration and to associate the effects of both therapies. Therefore, the objective of this study was to investigate the effects of iontophoresis along with GNPs in the skeletal muscle of rats exposed to a traumatic muscle injury. We utilised 50 Wistar rats randomly divided in to five experimental groups (n = 10): Control group (CG); Muscle injury group (MI); MI + GNPs (20 nm, 30 mg kg-1); MI + Microcurrent (300 µA); and MI + Microcurrent + GNPs. The treatment was performed daily for 7 days, with the first session starting at 24 h after the muscle injury. The animals were sacrificed and the gastrocnemius muscle was surgically removedand stored for the proper evaluations. The group that received iontophoresis with GNPs showed significant differences in inflammation and oxidative stress parameters and in the histopathological evaluation showed preserved morphology. In addition, we observed an improvement in the locomotor response and pain symptoms of these animals. These results suggest that the association of boththerapies accelerates the inflammatory response of the injured limb.


Subject(s)
Gold/chemistry , Iontophoresis/methods , Metal Nanoparticles/administration & dosage , Muscle, Skeletal/drug effects , Animals , Disease Models, Animal , Inflammation/drug therapy , Inflammation/pathology , Male , Muscle, Skeletal/injuries , Oxidative Stress/drug effects , Rats , Rats, Wistar
3.
Biochem Cell Biol ; 93(6): 548-57, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26583437

ABSTRACT

This study evaluated the parameters of oxidative stress and energy metabolism after the acute and long-term administration of gold nanoparticles (GNPs, 10 and 30 nm in diameter) in different organs of rats. Adult male Wistar rats received a single intraperitoneal injection or repeated injections (once daily for 28 days) of saline solution, GNPs-10 or GNPs-30. Twenty-four hours after the last administration, the animals were killed, and the liver, kidney, and heart were isolated for biochemical analysis. We demonstrated that acute administration of GNPs-30 increased the TBARS levels, and that GNPs-10 increased the carbonyl protein levels. The long-term administration of GNPs-10 increased the TBARS levels, and the carbonyl protein levels were increased by GNPs-30. Acute administration of GNPs-10 and GNPs-30 increased SOD activity. Long-term administration of GNPs-30 increased SOD activity. Acute administration of GNPs-10 decreased the activity of CAT, whereas long-term administration of GNP-10 and GNP-30 altered CAT activity randomly. Our results also demonstrated that acute GNPs-30 administration decreased energy metabolism, especially in the liver and heart. Long-term GNPs-10 administration increased energy metabolism in the liver and decreased energy metabolism in the kidney and heart, whereas long-term GNPs-30 administration increased energy metabolism in the heart. The results of our study are consistent with other studies conducted in our research group and reinforce the fact that GNPs can lead to oxidative damage, which is responsible for DNA damage and alterations in energy metabolism.


Subject(s)
Energy Metabolism/drug effects , Gold/toxicity , Heart/drug effects , Kidney/drug effects , Liver/drug effects , Metal Nanoparticles/toxicity , Oxidative Stress/drug effects , Animals , Biomarkers/metabolism , Citric Acid Cycle/drug effects , Drug Delivery Systems/adverse effects , Gold/administration & dosage , Gold/analysis , Gold/chemistry , Injections, Intraperitoneal , Kidney/chemistry , Kidney/enzymology , Kidney/metabolism , Liver/chemistry , Liver/enzymology , Liver/metabolism , Male , Metal Nanoparticles/administration & dosage , Metal Nanoparticles/chemistry , Metal Nanoparticles/ultrastructure , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/metabolism , Myocardium/chemistry , Myocardium/enzymology , Myocardium/metabolism , Particle Size , Protein Carbonylation/drug effects , Rats, Wistar , Tissue Distribution , Toxicity Tests, Acute , Toxicity Tests, Subacute , Toxicokinetics
4.
Clinics (Sao Paulo) ; 68(2): 173-8, 2013.
Article in English | MEDLINE | ID: mdl-23525312

ABSTRACT

OBJECTIVE: To determine the relationship between enteral nutrition discontinuation and outcome in general critically ill patients. MATERIALS AND METHODS: All patients admitted to a mixed intensive care unit in a tertiary care hospital from May-August 2009 were screened for an indication for enteral nutrition. Patients were followed up until leaving the intensive care unit or a maximum of 28 days. The gastrointestinal failure score was calculated daily by adding values of 0 if the enteral nutrition received was identical to the nutrition prescribed, 1 if the enteral nutrition received was at least 75% of that prescribed, 2 if the enteral nutrition received was between 50-75% of that prescribed, 3 if the enteral nutrition received was between 50-25% of that prescribed, and 4 if the enteral nutrition received was less than 25% of that prescribed. RESULTS: The mean, worst, and categorical gastrointestinal failure scores were associated with lower survival in these patients. Age, categorical gastrointestinal failure score, type of admission, need for mechanical ventilation, sequential organ failure assessment, and Acute Physiologic and Chronic Health Evaluation II scores were selected for analysis with binary regression. In both models, the categorical gastrointestinal failure score was related to mortality. CONCLUSION: The determination of the difference between prescribed and received enteral nutrition seemed to be a useful prognostic marker and is feasible to be incorporated into a gastrointestinal failure score.


Subject(s)
Critical Illness/therapy , Enteral Nutrition/methods , Adult , Age Distribution , Aged , Brazil , Critical Illness/mortality , Epidemiologic Methods , Female , Gastrointestinal Tract/physiopathology , Humans , Intensive Care Units , Male , Middle Aged , Prognosis , Time Factors , Treatment Outcome
5.
Clinics ; Clinics;68(2): 173-178, 2013. ilus, tab
Article in English | LILACS | ID: lil-668803

ABSTRACT

OBJECTIVE: To determine the relationship between enteral nutrition discontinuation and outcome in general critically ill patients. MATERIALS AND METHODS: All patients admitted to a mixed intensive care unit in a tertiary care hospital from May-August 2009 were screened for an indication for enteral nutrition. Patients were followed up until leaving the intensive care unit or a maximum of 28 days. The gastrointestinal failure score was calculated daily by adding values of 0 if the enteral nutrition received was identical to the nutrition prescribed, 1 if the enteral nutrition received was at least 75% of that prescribed, 2 if the enteral nutrition received was between 50-75% of that prescribed, 3 if the enteral nutrition received was between 50-25% of that prescribed, and 4 if the enteral nutrition received was less than 25% of that prescribed. RESULTS: The mean, worst, and categorical gastrointestinal failure scores were associated with lower survival in these patients. Age, categorical gastrointestinal failure score, type of admission, need for mechanical ventilation, sequential organ failure assessment, and Acute Physiologic and Chronic Health Evaluation II scores were selected for analysis with binary regression. In both models, the categorical gastrointestinal failure score was related to mortality. CONCLUSION: The determination of the difference between prescribed and received enteral nutrition seemed to be a useful prognostic marker and is feasible to be incorporated into a gastrointestinal failure score.


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Critical Illness/therapy , Enteral Nutrition/methods , Age Distribution , Brazil , Critical Illness/mortality , Epidemiologic Methods , Gastrointestinal Tract/physiopathology , Intensive Care Units , Prognosis , Time Factors , Treatment Outcome
6.
Fisioter. Bras ; 13(5): 371-374, Set.-Out. 2012.
Article in Portuguese | LILACS | ID: lil-764811

ABSTRACT

Introdução: Este estudo teve como objetivo comparar os efeitos do ultrassom terapêutico e da auto-hemoterapia no tratamento da lesão muscular. Material e métodos: Foram utilizados 24 ratos Wistar, divididos aleatoriamente em quatro grupos: G1: Ratos sem lesão muscular; G2: Ratos com lesão muscular sem tratamento; G3:Ratos com lesão muscular e tratamento com ultrassom pulsado (0.8W/cm2); G4: Ratos com lesão muscular e tratamento com auto--hemoterapia. A lesão muscular foi induzida por um trauma único no gastrocnêmio. O tratamento foi realizado durante 7 dias e os animais foram eutanasiados por decapitação e o tecido muscular ao redor da lesão foi removido cirurgicamente para a realização das análises bioquímicas. Dentre os marcadores bioquímicos foram analisados ânion superóxido como marcador na produção de espécies reativas de oxigênio, e catalase como marcador de enzimas antioxidantes. Resultados: O grupo 2 apresentou diferença significativa em relação ao grupo 1 tendo aumentado o estresse oxidativo, e o grupo 3 apresentou diminuição do estresse oxidativo estatisticamente significativa em relação ao grupo 2, o grupo 4 não apresentou diferença significativa. Conclusão: Nota-se que a auto-hemoterapia não apresentou resultados satisfatórios no tratamento de lesão muscular,ao contrário do ultrassom, que diminuiu os marcadores de estresse oxidativo sendo eficaz no tratamento de lesão muscular.


Introduction: This study aimed to compare the effects of therapeutic ultrasound and autohemotherapy to treat muscle injury. Methods: Twenty four Wistar rats were randomly divided into four groups: G1: Rats with no muscle injury; G2: Rats with muscle injury without treatment; G3: Rats with muscle injury and treatment using pulsed ultrasound (0.8 W/cm²); G4: Rats with muscle injury and treatment using autohemotherapy. The muscle injury was inducedby a single trauma on the gastrocnemius. The treatment was carriedout during 7 days and the animals were euthanized by decapitation and the muscle tissue around the injury was surgically removed toper form biochemistry analyses. Among the biochemical markerswere analyzed superoxide anion as a marker of reactive oxygen species production and catalase as antioxidant enzymes. Results: Group 2showed significant difference compared to group 1 and increased oxidative stress, and group 3 showed a reduction of statistically significant oxidative stress compared to group 2, group 4 showedno significant difference. Conclusion: Was observed that the muscle injury treatment using autohemotherapy has no satisfactory results.On the other hand, ultrasound therapy reduced the oxidative stress markers and has proved effective in treating muscle injury.


Subject(s)
Animals , Rats , Autohemotherapy/adverse effects , Myalgia/therapy , Ultrasonic Therapy/methods , Rats, Wistar
7.
Mol Cell Biochem ; 342(1-2): 51-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20411305

ABSTRACT

Silver has been used for years in medicine; it has known antimicrobial properties. Additionally, silver has been used in water and air filtration to eliminate microorganisms, and, more recently, as a biocide to prevent infections in burns. In contact with the human body, nanoparticles can elicit a spectrum of tissue responses such as the generation of reactive oxygen species, decreased function of mitochondria and even cell death. Mitochondries are intracellular organelles that play a crucial role in ATP production. In the present work, we evaluate the in vitro effect of silver nanoparticles (AgN) on the activities of mitochondrial respiratory chain complexes from the brain, skeletal muscle, heart, and liver of rats. Our results demonstrated that AgN (10, 25, and 50 mg l(-1)) decreases the activity of mitochondrial respiratory chain complexes I, II, III, and IV from all tissues.


Subject(s)
Electron Transport Chain Complex Proteins/metabolism , Electron Transport/drug effects , Mitochondria, Heart/drug effects , Mitochondria, Liver/drug effects , Mitochondria, Muscle/drug effects , Mitochondria/drug effects , Silver Nitrate/pharmacology , Animals , Brain/drug effects , Electron Transport Complex I/metabolism , Electron Transport Complex II/metabolism , Electron Transport Complex III/metabolism , Electron Transport Complex IV/metabolism , Male , Mitochondria, Heart/enzymology , Mitochondria, Liver/enzymology , Mitochondria, Muscle/enzymology , Nanoparticles , Oxidative Stress/drug effects , Oxygen Consumption/drug effects , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
8.
Redox Rep ; 10(3): 139-43, 2005.
Article in English | MEDLINE | ID: mdl-16156952

ABSTRACT

Many biological properties have been attributed to ruthenium complexes including anti-tumor activity and the attenuation of reperfusion damage and infarct size. In this work, we characterize the antioxidant activity of trans-[RuCl2(nic)4] where nic is 3-pyridinecarboxylic acid and trans-[RuCl2(i-nic)4] where i-nic is 4-pyridinecarboxylic acid by (i) evaluation of total antioxidant potential (TRAP); (ii) prevention of DNA damage induced by hydrogen peroxide using the alkaline comet assay; and (iii) the prevention of lipid peroxidation and cell death induced by iron in liver slices. Our results suggest that nic has stronger antioxidant potential when compared to the i-nic. Higher doses (above 200 microM) of these compounds gave genotoxic effects, but the antioxidant potential could be obtained with the use lower doses (0.1-10 microM).


Subject(s)
Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Ruthenium Compounds/pharmacology , Ruthenium/pharmacology , Animals , Antioxidants/metabolism , Comet Assay , DNA Damage , Isonicotinic Acids/pharmacology , Lipid Peroxidation , Liver/metabolism , Niacin/pharmacology , Oxidative Stress , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL